Silo Pharma Filed A PCT Patent Application Related To Methods Of Treating Alzheimer's Disease And Ameliorating Symptoms Associated With Alzheimer's Disease Using Prucalopride And Ketamine - 8K
Portfolio Pulse from Benzinga Newsdesk
Silo Pharma has filed a PCT patent application for methods of treating Alzheimer's disease and ameliorating symptoms associated with Alzheimer's disease using Prucalopride and Ketamine.
August 31, 2023 | 11:48 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Silo Pharma's patent application could potentially lead to a new treatment for Alzheimer's disease, which could significantly boost the company's revenues if approved and successful.
The filing of a patent application indicates that Silo Pharma is making progress in its research and development efforts. If the patent is granted and the treatment proves to be effective, it could lead to increased revenues for the company. However, it's important to note that the process of getting a drug approved is long and uncertain, and there's no guarantee of success.
CONFIDENCE 70
IMPORTANCE 80
RELEVANCE 100